YoshimitsuSuda

Small Molecule Therapeutics The Novel VEGF Receptor / MET – Targeted Kinase Inhibitor TAS-115 Has Marked In Vivo Antitumor Properties and a Favorable Tolerability Pro fi le

Masanori Kato, Kimihiro Ito, S. Ito, 2013 .